What ketamine dose and infusion rate should be used for a 100‑kg intubated, agitated, hypotensive adult?

Ketamine Dosing and Infusion for Agitated, Hypotensive, Intubated 100-kg Patient

For a 100-kg intubated, agitated, hypotensive adult, administer ketamine 100-200 mg IV bolus (1-2 mg/kg) followed by continuous infusion starting at 0.5 mg/kg/hour (50 mg/hour), titrating upward by 0.2 mg/kg/hour every 30 minutes as needed to achieve adequate sedation (RASS -1 to -2), with maximum infusion rates up to 5 mg/kg/hour (500 mg/hour) if required. 1, 2, 3

Initial Bolus Dosing

• Administer 100-200 mg IV bolus (1-2 mg/kg) over 2-3 minutes for rapid sedation in this hypotensive patient, as ketamine's sympathomimetic properties help maintain blood pressure during induction. 4, 2

• The 1-2 mg/kg dose range is specifically recommended by the American Society of Anesthesiologists for hemodynamically unstable patients requiring sedation, as it provides adequate dissociation while preserving cardiovascular stability. 2

• Avoid doses exceeding 2 mg/kg, as higher doses (>2 mg/kg) are associated with significantly increased odds of hypotension (OR 7.0), bradycardia (OR 7.5), and oxygen desaturation (OR 6.0) even in trauma populations. 5

Continuous Infusion Protocol

• Start infusion at 0.5 mg/kg/hour (50 mg/hour for 100-kg patient) immediately after bolus administration. 3

• Titrate upward by 0.2 mg/kg/hour (20 mg/hour increments) every 30 minutes until target sedation (RASS -1 to -2) is achieved. 3

• Maximum infusion rate is 5 mg/kg/hour (500 mg/hour), though most patients achieve adequate sedation at lower rates. 3

• The infusion provides sustained sedation and analgesia without the respiratory depression or hypotension associated with opioids and benzodiazepines, making it particularly advantageous in hypotensive patients. 3

Critical Hemodynamic Management

Maintain systolic blood pressure >110 mmHg and mean arterial pressure >80 mmHg throughout sedation, as hypotension is the primary threat to outcome in critically ill patients. 1, 2, 6

• Have vasopressors immediately available (norepinephrine 0.01-0.5 μg/kg/min as first-line, with ephedrine or metaraminol for bolus rescue). 1, 2, 6

• Despite ketamine's sympathomimetic properties, patients with depleted catecholamine stores from prolonged shock may still develop hypotension, requiring vasopressor support. 4

• Establish invasive arterial blood pressure monitoring before or immediately after ketamine administration to enable continuous hemodynamic assessment. 1, 2

Ventilation Requirements

Ketamine must be used with controlled mechanical ventilation targeting PaCO₂ 4.5-5.0 kPa (34-38 mmHg) and PaO₂ ≥13 kPa (98 mmHg) to prevent cerebral vasoconstriction and ICP elevation. 1, 2

• Monitor end-tidal CO₂ continuously and adjust ventilation to maintain normocapnia, as both hypercapnia (>6 kPa) and hypocapnia (<4 kPa) worsen outcomes. 1

• Ketamine preserves respiratory drive but does not eliminate the need for mechanical ventilation in intubated patients. 3

Adjunctive Medications

Co-administer high-dose fentanyl 3-5 μg/kg (300-500 μg for 100-kg patient) with the initial ketamine bolus to provide additional analgesia and minimize hemodynamic fluctuations. 1, 2

• Pretreat with atropine 0.02-0.05 mg/kg or glycopyrrolate to attenuate excessive airway secretions caused by ketamine. 2

• Avoid benzodiazepines and additional opioids during the first 24-48 hours, as ketamine alone typically provides adequate sedation and analgesia while reducing vasopressor requirements. 3

Duration and Transition Strategy

• Continue ketamine infusion for up to 48 hours as the primary sedative in hypotensive patients, as this approach demonstrates trends toward decreased vasopressor requirements and reduced need for additional sedatives. 3

• After 48 hours, transition to standard ICU sedation protocol (typically dexmedetomidine or propofol) if continued sedation is required, as prolonged ketamine use beyond this timeframe lacks robust safety data. 4, 3

• The transition should be gradual, starting the alternative sedative before discontinuing ketamine to prevent emergence reactions. 4

Monitoring and Safety

Monitor for emergence reactions (3.5% incidence), transient hypoxia (1.8%), and laryngospasm (1.3%), though these complications are uncommon and usually self-limiting. 7

• Target blood glucose 6-10 mmol/L (108-180 mg/dL) during the acute phase, as both hypo- and hyperglycemia worsen outcomes in critically ill patients. 1

• Assess for adequate sedation every 30 minutes during titration and hourly once stable, using RASS scoring to guide dose adjustments. 3

• Intubation rates are significantly lower (1.8%) when ketamine is administered to already-intubated ED patients compared to prehospital use, indicating excellent safety in this population. 7

Common Pitfalls to Avoid

• Do not use 4% albumin solutions for volume resuscitation in conjunction with ketamine, as albumin increases mortality (41.8% vs 22.2%) in critically ill patients. 1

• Do not delay vasopressor initiation waiting for ketamine's sympathomimetic effects to manifest, as depleted catecholamine stores may prevent the expected blood pressure support. 4, 6

• Do not administer ketamine as sole therapy without mechanical ventilation and CO₂ monitoring, as uncontrolled ventilation can lead to dangerous ICP elevations. 1, 2